World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma SharesGlobeNewsWire · Oct 8, 2026
Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High – Time to Buy?Defense World · Oct 6, 2026
Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple SclerosisGlobeNewsWire · Oct 6, 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.GlobeNewsWire · Sep 30, 2026
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEOGlobeNewsWire · Sep 24, 2026
Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price TargetGlobeNewsWire · Sep 17, 2026Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development. Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.42 | -$0.47 | Miss |
| May 7, 2026 | -$0.41 | -$3.06 | Miss |
| Mar 27, 2026 | -$1.02 | -$0.19 | Beat |
| Nov 7, 2025 | -$0.20 | -$1.25 | Miss |
| Aug 6, 2025 | -$0.17 | -$3.23 | Miss |
| May 14, 2025 | -$0.37 | -$1.41 | Miss |